No abstract

High-dose 17beta-estradiol was moderately effective in reducing final height and should probably be reserved for selected patients, particularly as knowledge on potential long-term side effects is lacking.

This 5-year observational study provides evidence that tibolone is effective in increasing BMD in postmenopausal women with osteopenia and osteoporosis during the first 2 years of treatment, but because BMD starts to decline in the third year, it is vital that postmenopausal women start treatment with tibolone as early as possible, so that bone mineral density levels are kept high as long as possible.

Clinical trials prove that tibolone is effective in the treatment of the menopausal symptoms and for the postponement and calming of symptoms accompanying age-related diseases. The findings of basic researchers that tibolone affects the metabolism of every cell, including malignant cells, opened a door to a whole new domain of research that has a promising future.

Poster abstracts revision of uterine cavity after spontaneous delivery the office hysteroscopy (HSC) without anaesthesia and dilatation to evaluate and eventually treat the intrauterine pathologies. We compared the results with previous ultrasound examination (US). Methods: We examinated at 6 weeks after delivery with vaginal ultrasound 141 patients. All patients were scheduled for office hysteroscopy. We divided women according the ultrasound into 3 groups: Group A-negative: endometrium less than 5 mm; Group B-suspicious: non-homogenous content from 5 to 10 mm; Group C-positive: hyper-echogenic content more than 10 mm. The ESGE classification was used for HSC description of IU adhesions. The residua were described as mild (< 15 mm) and severe (> 15 mm). Results: In group A we classified 61 (43.3%) in group B 36 (25.5%) and in group C 44 (31.2%) patients. Results are described in the